Moderna MRNA
NASDAQ MRNA
$194.82 +12.71 (+6.98%)
At close: Sep 24, 2026 · 4:00 PM EDT

Moderna (MRNA) Price to Sales (2018 - 2026)

Moderna's (MRNA) quarterly Price to Sales came in at 192.7 in Q2 2026, up 154.96% year-over-year from 75.58 in Q2 2025, and up 271.69% quarter-over-quarter from 51.84 in Q1 2026.

Analysis

Moderna (MRNA) Price to Sales (2018 - 2026) Analysis & Trends

Moderna (MRNA) has reported Price to Sales for 9 consecutive years, with 192.7 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Price to Sales rose 154.96% year-over-year to 192.7 in Q2 2026; TTM through Jun 2026 was 12.54, a 259.67% increase from a year earlier, with the FY2025 full-year figure at 5.98, up 20.51% from the prior year.
  • Price to Sales was 192.7 for Q2 2026 at Moderna, up from 51.84 in the prior quarter.
  • Over five years, Price to Sales peaked at 244.39 in Q1 2024 and troughed at 9.94 in Q3 2025.
  • A 5-year average of 64.69 and a median of 19.32 in 2025 frame the typical range for Price to Sales.
  • Across the five-year window, Price to Sales jumped 1041.24% in 2023 and tumbled 60.05% in 2025, its largest moves.
  • Over 5 years, Price to Sales stood at 13.6 in 2022, then retreated by 0.64% to 13.51 in 2023, then gained by 22.94% to 16.61 in 2024, then rose by 3.14% to 17.14 in 2025, then surged by 1024.47% to 192.7 in 2026.
  • The last three Price to Sales figures came in at 192.7 (Q2 2026), 51.84 (Q1 2026), and 17.14 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn
10 Moderna 72.66 Bn 67.52 Bn 52.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 192.70
Mar 31, 2026 51.84
Dec 31, 2025 17.14
Sep 30, 2025 9.94
Jun 30, 2025 75.58
Mar 31, 2025 101.59
Dec 31, 2024 16.61
Sep 30, 2024 13.82
Jun 30, 2024 189.21
Mar 31, 2024 244.39
Dec 31, 2023 13.51
Sep 30, 2023 21.49
Jun 30, 2023 134.57
Mar 31, 2023 31.67
Dec 31, 2022 13.60
Sep 30, 2022 13.60
Jun 30, 2022 11.79
Mar 31, 2022 11.36
Dec 31, 2021 14.19
Sep 30, 2021 31.37
API Access

Moderna Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=MRNA&period=max&api_key=YOUR_API_KEY